Publicaciones en colaboración con investigadores/as de Essen University Hospital (1)

2016

  1. Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib: Phase III randomized LUX-Lung 5 trial

    Annals of Oncology, Vol. 27, Núm. 3, pp. 417-423